ARTICLE | Company News
Dyax, Urrma deal
October 27, 2003 8:00 AM UTC
The companies partnered to discover and develop anti-R7V antibodies to treat HIV. DYAX will use its antibody libraries to identify anti-R7V candidates, and Urrma will evaluate the ability of leads to ...